FDA committee recommends granting of marketing approval to Savient's Krystexxa for gout June 17, 2009
GSK claims calcium receptor antagonists for the treatment of bone and bone mineral disorders June 17, 2009
Roche discovers farnesoid X receptor agonists for the treatment of lipoprotein disorders June 16, 2009
G-15, a highly selective GRP30 antagonist, may be useful in the regulation of estrogen signaling June 15, 2009
Glucokinase activator MK-0599 lowers blood glucose in normoglycemic subjects in phase I trial June 12, 2009
RSS